Compared to untreated patients, LES-treated patients had significantly more advanced liver disease in terms of laboratory variables (albumin, sodium, INR, and platelet count) and liver function (Child–Pugh score and class and MELD score). The gene discussed is ALB; the disease is liver disorder.